About NovaLead Pharma
NovaLead Pharma is a company based in Pune (India) founded in 2007 by Ajay Aslekar, Girish Lakhe, Sayali Aslekar, Prerna Deshpande, Atul Aslekar, and Supreet Deshpande. NovaLead Pharma has raised $8.04 million across 4 funding rounds from investors including Tata Capital Healthcare Fund, Boxmoor Mauritius and BIRAC. NovaLead Pharma operates in a competitive market with competitors including Aclaris Therapeutics, BiomX, Alumis, Elektrofi and Rani Therapeutics, among others.
- Headquarter Pune, India
- Founders Ajay Aslekar, Girish Lakhe, Sayali Aslekar, Prerna Deshpande, Atul Aslekar, Supreet Deshpande
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novalead Pharma Private Limited
- Date of Incorporation 31 Oct, 2007
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$705.86 K (USD)513.86as on Mar 31, 2023
-
Net Profit
$413.23 K (USD)353.23as on Mar 31, 2023
-
EBITDA
-$33.24 K (USD)53.09as on Mar 31, 2023
-
Total Equity Funding
$8.04 M (USD)
in 4 rounds
-
Latest Funding Round
$3.15 M (USD), Series B
Jul 17, 2015
-
Investors
Tata Capital Healthcare Fund
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NovaLead Pharma
NovaLead Pharma has successfully raised a total of $8.04M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.15 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NovaLead Pharma
NovaLead Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Tata Capital Healthcare Fund, Boxmoor Mauritius and BIRAC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund investing in healthcare and lifesciences in India.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for NovaLead Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NovaLead Pharma
Investment portfolio details for NovaLead Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NovaLead Pharma
Detailed financials for NovaLead Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novalead Pharma Comparisons
Peer comparison for NovaLead Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NovaLead Pharma
NovaLead Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, BiomX, Alumis, Elektrofi and Rani Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel dermatologic therapies are developed for skin conditions.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics are developed for dysbiosis-linked diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for autoimmune diseases are developed by Alumis.
|
|
| Locked | Locked | Locked |
Digital platform transforming the delivery of biologic medicines
|
|
| Locked | Locked | Locked |
Technology for oral delivery of large drug molecules is developed.
|
|
| Locked | Locked | Locked |
Developer of biosimilar drugs for the treatment of multiple diseases
|
Detailed competitors of NovaLead Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novalead Pharma
Complete news archive for NovaLead Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NovaLead Pharma
NovaLead Pharma was founded in 2007 and raised its 1st funding round 3 years after it was founded.
NovaLead Pharma is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Supreet Deshpande is the current CEO of NovaLead Pharma. They have also founded this company.
NovaLead Pharma is a funded company, having raised a total of $8.04M across 4 funding rounds to date.
Annual revenue of NovaLead Pharma is $705.86K as on Mar 31, 2023.
NovaLead Pharma was founded in 2007 in Pune, India, within the pharmaceutical sector. Drug repurposing and discovery services are delivered through a proprietary technology platform. Key developments include Galnobax, a topical esmolol gel for diabetic foot ulcers, and NLP91, a repurposed generic for psoriasis treatment. Operations center on biotech innovation and therapeutic applications in dermatology and wound care.
NovaLead Pharma's top competitors include Elektrofi, Aclaris Therapeutics and Samsung Bioepis.
NovaLead Pharma has 3 investors. Key investors include Tata Capital Healthcare Fund, Boxmoor Mauritius, and BIRAC.
The valuation of NovaLead Pharma is $30.96M as of Jul 2015.